Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Teva and Takeda enter into new venture for generics in Japan

Executive Summary

Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Co. Ltd. entered into a new partnership in Japan. The new venture will begin in Q2 2016 with Teva owning 51% and Takeda 49%. The partnership will operate as an independent company with its own board and management team. Further details have not yet been disclosed.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Joint Venture
    • Marketing (Licensing)

Related Companies